Harnessing the power of light at specific wavelengths and dose has profound stimulatory or inhibitory effects on cellular behaviour (photobiomodulation) and bacterial growth and viability. These characteristics can be harnessed to provide non-invasive therapeutic interventions important in modulating inflammation, infection, maintaining cell viability, analgesia and promotion of wound healing.
Professor William Palin
Principal Investigator & Group Lead
Professor Michael Milward
Principal Investigator & Group Lead
Dr Andrew Stevens
Dr David Davies
Our research group
The group draws on expertise across cell and molecular biology, microbiology, optoelectronics, biophotonics, and has expertise for clinical translation with collaborations across a broad spectrum of clinical disciplines including medicine, veterinary sciences, and dentistry. These collaborations aim to deliver novel therapeutic interventions for traumatic brain injury, periodontitis (gum disease), local and systemic infections, musculoskeletal disorders, skin disease, cardiovascular disease, neuropathic pain, and traumatic wound infection/repair.
Our multidisciplinary group works towards understanding the fundamental principles of photobiomodulation and its application towards clinical translation. The research and translational developments are underpinned by funding from the UK Research Councils, NIHR, Ministry of Defence and industry. We demonstrate the therapeutic effects and dose optimisation required for beneficial biological responses towards the development of innovative medical devices. Recently, our work has resulted in securing the intellectual property relating to the invasive delivery of near infrared light for the treatment of traumatic brain injury.
The overarching aims of the Phototherapy Research Group, include:
- Understanding tissular, cellular and molecular mechanisms that underpin phototherapy.
- Developing novel approaches to bacterial decontamination
- Developing novel in vitro tools for high-throughput analysis in order to study the efficacy of light therapy in a range of treatment needs.
- Modelling light transmission through relevant tissues in order to optimise light dosing parameters.
- Developing simultaneous light treatment regimes to inhibit and remove infections that may impede wound repair.
- Understanding patient needs and to identify the most appropriate light therapy delivery approach to enable the development of novel devices for a range of clinical needs.
An Invasive theranostic optical central nervous system interface, developing an functional prototype for use in traumatic brain injuries.
Funder: Midland Neuroscience Research Fund; July 2020 – June 2021
Portable PHOTOtherapy devices for maintaining tissue viability and accelerated wound REPair (PHOTOREP)
Funder: Defence Science and Technology Laboratory (Dstl), Ministry of Defence; Sept 2018 – May 2021
Development of Novel Phototherapy Technology for Decontamination and Accelerated Wound Healing.
Funder: EPSRC/Dstl; Jan 2018 – Dec 2021
- Halstead FD, Hadis MA, Milward M, Cooper PR, Oppenheim B, Palin WM (2019). Enhanced antimicrobial activity for photodisinfection of monomicrobial nosocomial related biofilms. Appl Environ Microbiol, 16;85: e01346-19.
- Serrage H, Heiskanen V, Palin WM, Cooper PR, Milward MR, Hadis M, Hamblin MR (2019). Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light. Photochem Photobiol Sci, 18: 1877-1909.
- Serrage H, Joanisse S, Cooper PR, Palin WM, Hadis M, Darch O, Philp A, Milward MR (2019). Differential responses of myoblasts and myotubes to photobiomodulation. J Biophotonics, 12: e201800411.
- Hadis MA, Cooper PR, Milward MR, Gorecki PC, Tarte E, Churm J, Palin WM (2017). Development and application of LED arrays for use in phototherapy research. J Biophotonics, 10: 1514-1525
- Hadis MA, Zainal SA, Holder MJ, Carroll JD, Cooper PR, Milward MR and Palin WM (2016). The dark art of light measurement: accurate radiometry for low-level light therapy. Lasers Med Sci, 31: 789-809.
- Hadis MA, Davies D and Palin WM, ‘Novel light based therapeutic device for the treatment of traumatic brain injury’, UK Patent Application No 2006201.4; Phototherapy Device; The University of Birmingham.
PI(s): Dr David Davies, Professor Paul Cooper, Dr Sarah Kuehne
Postdocs: Farah Raja
Students: Rebecca Mungall, Mark Cronshaw